Answers are grounded in this paper and cite their sources.
Introduction: Neonatal sepsis is an important cause of morbidity and mortality in developing countries.Early diagnosis and treatment is necessary in order to mitigate this trend.Procalcitonin is one of the acute phase reactants meant for this purpose.The objective of the study was to determine the usefulness of procalcitonin as an early marker in the diagnosis of neonatal sepsis in University of Calabar Teaching Hospital, Calabar, Nigeria.Methods: This was a prospective case-control hospital-based study conducted from September, 2017 to April, 2018 among 60 neonates with suspected sepsis admitted into the newborn unit as well as healthy 60 age and sex-matched controls.Socio-demographic data, presenting complaints and risk factors for sepsis among others, were obtained using the pre-tested questionnaire.The history suggestive of sepsis included a history of prolonged rupture of membranes, peripartum pyrexia, prolonged labour, fever, fast breathing, convulsions among others.Physical examination was done with focus on signs suggestive of sepsis such as temperature instability, tachypnoea, dyspnoea, seizures, abdominal distension.Samples for procalcitonin test were collected along with samples for routine sepsis workup and blood smear for malaria parasite at presentation.Blood culture was done for anaerobic and aerobic organisms.The serum samples were pooled and analyzed for procalcitonin using quantitative ELISA test.Data was analyzed using SPSS version 20 and p< 0.05 was taken as statistically significant.Result: Out of the 60 subjects, 19 (31.7%) had blood culture positive sepsis, 36 (60.0%) had blood culture negative sepsis and 5 (8.3%) had neonatal malaria.The gram positive organisms accounted for 13 (68.4%) of the 19 bacteria isolated.Of the 36 neonates with blood culture negative sepsis, 31(86.1%)neonates had clinical signs and/or haematological parameters suggestive of sepsis.In addition, 3(8.3%) neonates had bronchopneumonia while 2(5.6%) had ophthalmia neonatorium.The median procalcitonin (PCT) level in the subjects compared with the controls was 0.98ng/ml and 0.40ng/ml respectively (p value = 0.000).The mean PCT level was 5.977.36ng/ml in the subjects and 1.583.64ng/ml in the controls.Among the subjects, the median PCT was 1.28ng/ml in blood culture negative sepsis and 0.93ng/ml in blood culture positive sepsis (p value = 0.000).In addition, the mean PCT level was also higher in neonates with blood culture negative sepsis (7.46 8.07ng/ml) when compared with blood culture positive sepsis (4.605.99ng/ml).Based on the receiver operating characteristics curve, PCT levels 0.5ng/ml was suggestive of bacterial infection.Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and area under the curve at PCT level of 0.5ng/ml were 68.4%, 29.3%, 30.0%, 66.7% and 0.51 respectively.Conclusion: These findings show that although serum PCT levels were higher in neonates with suspected sepsis when compared to the healthy babies, they were nevertheless lower in culture proven sepsis (septicaemia).PCT was insignificant as an acute phase reactant because of its low specificity and PPV in our environment.
No takes yet. Share an insight, caveat, or question.
Ni et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: